Curaleaf enters European cannabis market with $286 million acquisition of Emmac Life Sciences
SWI Editorial Staff2021-06-09T16:37:00-07:00By John Schroyer Curaleaf Holdings said Tuesday it signed a $286 million definitive agreement to acquire London-based medical marijuana company Emmac Life Sciences, giving the Massachusetts-based multistate operator a major foothold in ...